Drug-induced male sexual dysfunction. An update

Area of Science:

• Urology
• Pharmacology
• Men's Health

Background:

• Impotence affects an estimated 10 million American men, with prevalence increasing with age.
• Commonly prescribed medications across various classes are linked to sexual dysfunction, impacting libido and ejaculation.
• Antihypertensive drugs are frequently associated with erectile dysfunction, while antipsychotics have reported links with less clinical investigation.

Purpose of the Study:

• To review the impact of commonly prescribed drugs on male sexual function.
• To highlight the importance of a comprehensive patient history in diagnosing impotence.
• To discuss current therapeutic options for erectile dysfunction.

Main Methods:

• Literature review of clinical experience and published reports on drug-induced sexual dysfunction.
• Analysis of drug classes commonly associated with impotence, including antihypertensives, antipsychotics, digoxin, clofibrate, cimetidine, hormonal agents, and antineoplastics.
• Overview of diagnostic approaches and treatment modalities for erectile dysfunction.

Main Results:

• A significant number of medications can cause or exacerbate impotence through various mechanisms.
• Detailed medical, surgical, sexual, and drug/substance abuse history is crucial for identifying contributing factors.
• Intracavernous alprostadil injections and vacuum constriction devices show promise as effective treatments.

Conclusions:

• Medication side effects are a significant contributor to impotence in men.
• A systematic approach involving thorough history taking and consideration of least invasive therapies is essential.
• Advanced treatment options, including intracavernous injections and improved penile prostheses, offer effective solutions for persistent erectile dysfunction.